In breast cancer, Sukocheva, O et al [55]demonstrated that E2-induced EGFR transactivation in human breast cancer cells is driven via a novel signaling system controlled by the lipid kinase sphingosine kinase-1 (SphK1). This evidence concerns the gene SPHK1 and breast carcinoma.